Journal of Microbiology

The Microbiological Society of Korea (한국미생물학회)
권호 표지

Effect of Mycelial Extract of Clavicorona pyxidata on Acetylcholinesterase and ${\beta}$-Secretase Activity in vitro

  • Lee, Tae-Hee (Department of Life Science, College of Natural Science, Dongguk University) ;
  • Park, Young-Il (Department of Biology, Graduate School, Dongguk University) ;
  • Han, Yeong-Hwan (Department of Life Science, College of Natural Science, Dongguk University)
  • Published : 2006.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

In a previous study, an extract of Clavicorona pyxidata DGUM 29005 mycelia demonstrated an inhibitory effect against enzyme-associated perceptual disorders. We have attempted to determine whether this mycelial extract is also capable of inhibiting the activities of acetylcholinesterase (AChE) and ${\beta}$-secretase (BACE) activity. Butanol, ethanol, and water extracts of C. pyxidata DGUM 29005 mycelia were shown to inhibit AChE activity by 99.3%, 93.7%, and 91.7%, respectively. The inhibitory value of the butanol extract was more profound than that of tacrine (95.4%). The ethanol extract also exerted an inhibitory effect against BACE activity; this fraction may harbor the potential for development into a pharmocotherapeutic modality for the treatment of Alzheimer's disease (AD) patients. Rat pheochromocytoma PC12 cells in culture were not determined to be susceptible to the cytotoxic activity evidenced by the mycelial extract. The ethanol extract inhibited endogenous AChE activity in PC12 cellular homogenates, with an $IC_{50}\;of\;67.5{\mu}g/ml$, after incubation with intact cells, and also inhibited BACE activity in a dose-dependent fashion. These results suggest that the C. pyxidata mycelial extract has the potential to enhance cholinergic function and, therefore, may perform a function in the amelioration of the cholinergic deficit observed in cases of AD, as well as other types of age-associated memory impairment.

Keywords

References

  1. Cai, H., Y. Wang, D. McCarthy, H. Wen, D.R. Borchelt, D.L. Price, and P.C. Wong. 2001. Nature Neuroscience 4, 233-234 https://doi.org/10.1038/85064
  2. Chemnitius, J.M., K.H. Haselmeye, B.D. Gonska, H. Kreuzer, and R. Zech. 1996. Indirect parasympathomimetic activity of metochlopramide: Reversible inhibition of cholinesterase from human central nervous system and blood. Pharmacol. Res. 34, 65-72 https://doi.org/10.1006/phrs.1996.9999
  3. Citron, M. 2004. $\beta$-Secretase inhibition for the treatment of Alzheimer's disease-promise and challenge. Trends Pharmacol. Sci. 25, 92-97 https://doi.org/10.1016/j.tips.2003.12.004
  4. Corner, J.H. 1970. A monograph of Clavaria and allied Genera. Beih. Nova Hedwigia 33, 1-299
  5. Coyle, J.T., D.L. Price, and M.R. Delong. 1983. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 219, 1184-1190 https://doi.org/10.1126/science.6338589
  6. Ellman, G.L., K.D. Courtney, Jr., V. Andres, and R.M. Featherstone. 1961. A new and rapid colorimetric determination of acetylcholineesterase activity. Biochem. Pharmacol. 7, 88-95 https://doi.org/10.1016/0006-2952(61)90145-9
  7. Enz, A., R. Amstutz, H. Boddeke, G. Gmelin, and J. Malanowski. 1993. Brain selective inhibition of acetylcho linesterase: A novel approach to therapy for Alzheimer's disease. Prog. Brain Res. 98, 431-438 https://doi.org/10.1016/S0079-6123(08)62429-2
  8. Ghosh, A.K., D. Shin, D. Downs, G. Koelsch, X. Lin, J. Ermolieff, and J. Tang. 2000. Design of potent inhibitors for human brain memapsin 2 ($\beta$-secretase). J. Am. Chem. Soc. 122, 3522-3523 https://doi.org/10.1021/ja000300g
  9. Ghosh, A.X., L. Hong, and J. Tang. 2002. $\beta$-secretase as a therapeutic target for inhibitor drugs. Curr. Med. Chem. 9, 1135-1144 https://doi.org/10.2174/0929867023370149
  10. Lee, H.J., J.S. Kim, G.Y. Heo, K.B. Lee, I.K. Rhee, and K.S. Song. 1999. Inhibitory activities of basidiomycetes on prolyl endopeptidase, acetylcholinesterase, and coagulation. J. Kor. Agr. Chem. Soc. 42, 336-343
  11. Lee, T.H. 2004. Ph. D. thesis. Dongguk University, Seoul, Korea
  12. Lee, T.H., J.M. Kim, and Y.H. Han. 2006. Optimized culture condition and enzyme activity of the mycelia of Clavicorona pyxidata. Kor. J. Microbiol. 41, 98-102
  13. Leung, D., G. Abbenante, and D.P. Fairlie. 2000. Protease inhibitors: current status and future prospects. J. Med. Chem. 43, 305-341 https://doi.org/10.1021/jm990412m
  14. Li, R., R.K. Lindholm, L.B. Yang, X. Yue, M. Citron, R. Yan, T Beach, L. Sue, M. Sabbagh, H. Cai, P. Wong, D. Price, and Y. Shen. 2004. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc. Nat. Acad. Sci. USA 101, 3632-3637
  15. Luo, Y., B. Bolon, S. Kahn, B.D. Bennett, S. Babu-Khan, P. Denis, W Fan, H. Kha, J. Zhang, Y. Gong, L. Martin, J.C. Louis, Q. Yan, W.G. Richards, M. Citron, and R. Vassar. 2001. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nature Neuroscience 4, 231-232 https://doi.org/10.1038/85059
  16. McGeer, P.L. and E.G. McGeer. 1995. Alzheimer's disease: Arthritis of the brain? Drug News Prospect 8, 80-83
  17. Miller, O.K. 1977. Mushrooms of North America, p. 158-162. In E.P. Dutton (ed.), Academic Press, New York, USA
  18. Page, M., N. Bejaoui, B. Cliq-Mars, and P. Lemieux. 1988. Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicity. Int. J. Immunol. 10, 85-793
  19. Parihar, M.S. and T. Hemnani. 2004. Alzheimer's disease pathogenesis and therapeutic interventions. J. Clin. Neurosci. 11, 456-467 https://doi.org/10.1016/j.jocn.2003.12.007
  20. Plattner, J.J. and D.W. Norbeck. 1990. Drug Discovery Technologies, p. 92-126. In C.R. Clark and W.H. Moos (ed.), Ellis Horwood Limited, Chichester, West Sussex
  21. Plumb, J.A., R. Milroy, and S.B. Kaye. 1989. Effect of the pH dependence of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide-formazon absorption on chemosensitivity determined by novel tetrazolium-based assay. Cancer Res. 49, 4435-4440
  22. Sinha, S., J.P. Anderson, R. Barbour, G.S. Basi, R. Caccavello, D. Davis, M. Doan, H.F. Dovey, N. Frigon, J. Hong, K. Jacobson-Croak, N. Jewett, P. Keim, J. Knops, I. Lieberburg, M. Power, H. Tan, G. Tatsuno, J. Tung, D. Schenk, and et al. 1999. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537 https://doi.org/10.1038/990114
  23. Wolfe, M.S. 2001. Secretase targets for Alzheimer's disease: identification and therapeutic potential. J. Med. Chem. 44, 2039-2060 https://doi.org/10.1021/jm0004897